Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea · Delayed Price · Currency is KRW 50,500
-2,100 (-3.99%)
At close: Jan 9, 2026
Hanall Biopharma Market Cap
Hanall Biopharma has a market cap or net worth of 2.56 trillion as of January 9, 2026. Its market cap has increased by 48.95% in one year.
Market Cap
2.56T
Enterprise Value
2.55T
Revenue
154.05B
Ranking
n/a
PE Ratio
1,109.97
Stock Price
50,500.00
Market Cap Chart
Since August 30, 1995, Hanall Biopharma's market cap has increased from 26.30B to 2.56T, an increase of 9,650.76%. That is a compound annual growth rate of 16.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 2.56T | 15.43% |
| Dec 30, 2025 | 2.22T | 13.35% |
| Dec 30, 2024 | 1.96T | -12.72% |
| Dec 28, 2023 | 2.25T | 148.89% |
| Dec 29, 2022 | 902.29B | -16.29% |
| Dec 30, 2021 | 1.08T | -43.84% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 87.26T |
| Celltrion | 46.60T |
| ALTEOGEN | 25.59T |
| ABL Bio | 11.88T |
| SK Biopharmaceuticals | 9.77T |
| Yuhan | 8.46T |
| LigaChem Biosciences | 6.71T |
| HLB Co., Ltd. | 6.71T |